These results demonstrate that KD of STAT1 in SCC61, a clinically derived tumour cell line not subjected to any experimental selection, leads to in vivo tumour growth suppression and radio sensitization similar to that observed previously in nu61. Here, STAT1 is linked to neoplasm.